Table 2.
RPMa program participation by eligible condition among survey respondents.
| RPM programs | Participation (N=3172), n (%) |
| Acute kidney injury | 7 (0.22) |
| Coronary artery disease | 24 (0.76) |
| CAR-Tb | 25 (0.79) |
| Cirrhosis | 8 (0.25) |
| General complex care | 13 (0.41) |
| COPDc | 21 (0.7) |
| COVID-19 | 2795 (88.11) |
| Congestive heart failure | 81 (2.55) |
| Hypertension | 87 (2.74) |
| Febrile neutropenia | 3 (0.09) |
| Other | 9 (0.28) |
| Post-ICUd | 1 (0.03) |
| Postsurgical | 98 (3.09) |
aRPM: remote patient monitoring.
bCAR-T: chimeric androgen receptor T-cell therapy.
cCOPD: chronic obstructive pulmonary disease.
dPost-ICU: postintensive care unit.